Biology Reference
In-Depth Information
Libby P, Warner SJ, Friedman GB (1988a) Interleukin 1: a mitogen for human vascular smooth
muscle cells that induces the release of growth-inhibitory prostanoids. J Clin Invest
81:487-498
Libby P, Warner SJ, Salomon RN, Birinyi LK (1988b) Production of platelet-derived growth
factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med
318:1493-1498
Limaye AP, Huang ML, Leisenring W, Stensland L, Corey L, Boeckh M (2001) Cytomegalovirus
(CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hemat-
opoietic stem-cell transplant recipients. J Infect Dis 183:377-382
Lockridge KM, Sequar G, Zhou SS, Yue Y, Mandell CP, Barry PA (1999) Pathogenesis of experi-
mental rhesus cytomegalovirus infection. J Virol 73:9576-9583
Lodoen M, Ogasawara K, Hamerman JA, Arase H, Houchins JP, Mocarski ES, Lanier LL (2003)
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral
gp40 modulation of retinoic acid early inducible 1 gene molecules. J Exp Med
197:1245-1253
Loebe M, Schuler S, Zais O et al (1990) Role of cytomegalovirus infection in the development of
coronary artery disease in the transplanted heart. J Heart Transplant 9:707-711
Lopez-Botet M, Llano M, Ortega M (2001) Human cytomegalovirus and natural killer-mediated
surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol Rev
181:193-202
Jarvis MA, Borton JA, Keech AM, Wong J, Britt WJ, Magun BE, Nelson JA (2006) Human
cytomegalovirus attenuates IL-1B and TNF proinflammatory signaling by inhibition of NFk- B
activation. J Virol 80:5588-5596
Manley TJ, Luy L, Jones T, Boeckh M, Mutimer H, Riddell SR (2004) Immune evasion proteins
of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural
infection. Blood 104:1075-1082
Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, Kaye S, Ojuola O,
Gillespie GM, Vargas Cuero AL, Cerundolo V, Callan M, McAdam KP, Rowland-Jones SL,
Donner C, McMichael AJ, Whittle H (2003) Mature CD8(+) T lymphocyte response to viral
infection during fetal life. J Clin Invest 111:1747-1755
Martelius TJ, Blok MJ, Inkinen KA, Loginov RJ, Hockerstedt KA, Bruggeman CA, Lautenschlager
IT (2001) Cytomegalovirus infection, viral DNA, and immediate early-1 gene expression in
rejecting rat liver allografts. Transplantation 71:1257-1261
Martelius TJ, Wolff H, Bruggeman CA, Hockerstedt KA, Lautenschlager IT (2002) Induction of
cyclo-oxygenase-2 by acute liver allograft rejection and cytomegalovirus infection in the rat.
Transpl Int 15:610-614
Martin-Davila P, Fortun J, Gutierrez C, Marti-Belda P, Candelas A, Honrubia A, Barcena R,
Martinez A, Puente A, de Vicente E, Moreno S (2005) Analysis of a quantitative PCR assay
for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
J Clin Virol 33:138-144
McCarthy M, Auger D, He J, Wood C (1998) Cytomegalovirus and human herpesvirus-6
trans-activate the HIV-1 long terminal repeat via multiple response regions in human fetal
astrocytes. J Neurovirol 4:495-511
McCormick AL, Skaletskaya A, Barry PA, Mocarski ES, Goldmacher VS (2003) Differential
function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the
viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in
primate and rodent cytomegaloviruses. Virology 316:221-233
McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT (1989) Association of coronary artery
disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol
64:359-362
McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA, Greenberg PD, Riddell
SR (1994) Identification of the major late human cytomegalovirus matrix protein pp65 as a
target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J Med Virol 43:103-110
